Rosiglitazone improves insulin sensitivity and glucose control, while lowering circulating vascular/inflammatory markers.
Read More »Diabetes In Control
ssue 164 Item 9 Late-Breaking Clinical Trial Results of the Carvedilol Vs. Metop
Carvedilol is Associated With A Significant Survival Benefit Over Metoprolol
Read More »Issue 164 Item 10 Pre-diabetes’ Raises Risk of Dying from Cancer
Having too much insulin in the blood may promote cancer production.
Read More »Issue 164 Item 11 Fish Insulin Discovery A Breakthrough In Diabetes Treatment
Scientists here have zeroed in on a new source of insulin in fish that mimics human insulin more closely than any known animal source — porcine or bovine — currently in use.
Read More »Issue 164 Item 12 Diabetes More Common in Snorers, Problem Sleepers
Pre-diabetes and diabetes occur more frequently in people who snore or who have a sleep disorder called sleep apnea
Read More »Issue 164 Item 13 Intensive Glycemic Control Pays Interest Before and After Reti
According to a new analysis from DCCT, intensive glycemic control is associated with reduced coronary calcification, a marker of atherosclerosis, years later — even if control has become less intense in the interim.
Read More »Issue 164 Item 14 Drug for Treating Type-2 Diabetes May Limit Heart Disease Risk
Rosiglitazone, may be a good choice for patients with type 2-diabetes who require additional medications to prevent heart attacks.
Read More »Issue 164 Item 15 Obesity Increases Risk for Death from Cancer
Researchers conclude that as many as 14% of cancer deaths in men and 20% of cancer deaths in women may be attributable to excess weight.
Read More »Issue 163 Item 1 ‘Impaired Glucose Tolerance Tied to Increased Risk of Cancer Mo
Hyperinsulinemia may promote cancer development, since insulin has been shown to stimulate cell growth, especially colonic epithelial cells.
Read More »Issue 163 Item 2 Diabetes Drugs Inappropriately Prescribed
Despite explicit warnings on package inserts, metformin and thiazolidinediones are often given to diabetics hospitalized with heart failure.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.